Page last updated: 2024-10-30

mesalamine and Monosomy

mesalamine has been researched along with Monosomy in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Monosomy: The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piccin, A1
Cortelazzo, S1
Rovigatti, U1
Bourke, B1
Smith, OP1

Other Studies

1 other study available for mesalamine and Monosomy

ArticleYear
Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia.
    American journal of hematology, 2010, Volume: 85, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Budesonide; Chromosomes, Human, Pair 7;

2010